Sustained Release Intraocular Drug Delivery Devices for Treatment of Uveitis

Sustained Release Intraocular Drug Delivery Devices for Treatment of Uveitis

Corticosteroids have been the mainstay of uveitis therapy. When intraocular inflammation is unresponsive to steroids, or steroid related side effects become a concern, steroid-sparing medications may be administered which can be classified into immunosuppressive and immunomodulatory agents. Uveitis...

Full description

Bibliographic Details
Main Authors: Nahid Haghjou, Masoud Soheilian, Mohammad Jafar Abdekhodaie
Format: Article
Language:English
Published: Knowledge E 2011-01-01
Series:Journal of Ophthalmic & Vision Research
Subjects:
Uveitis; Drug Delivery; Sustained-release; Corticosteroid; Steroid-sparing Medications
Online Access:http://www.jovr.org/article.asp?issn=2008-322X;year=2011;volume=6;issue=4;spage=317;epage=329;aulast=Haghjou

Internet

http://www.jovr.org/article.asp?issn=2008-322X;year=2011;volume=6;issue=4;spage=317;epage=329;aulast=Haghjou

Similar Items